Integrated transcriptomic, proteomic and flow cytometry analyses reveal that STAT1 negatively regulates MAIT cell effector and glycolytic functions, while STAT3, STAT5 and HIF1α act as positive modulators. Targeting these pathways may offer new strategies to restore MAIT cell function in immune dysregulation and cancer.
Olivia J. Cheng +7 more
wiley +1 more source
Les liaisons dangereuses: Immunological synapse formation in animals and plants [PDF]
Kwon, C. +2 more
core +1 more source
Human tolerogenic dendritic cell subtypes exert divergent effects on induction of cytotoxic CD4<sup>+</sup> T cells. [PDF]
Barran G +5 more
europepmc +1 more source
Genetic Susceptibility to Periodontitis
Aim: The aim of this narrative review was to identify genes carrying risk alleles associated with an increased risk of periodontitis and to place them in a biological context. Methods: The literature was reviewed based on predefined criteria. Results: The identified genes largely fall into functions linking immune response with tissue repair. The genes
Gesa M. Richter, Arne S. Schaefer
wiley +1 more source
Changes in circulating NK and innate-like T cells in type 1 and type 2 diabetes. [PDF]
Loguinova M +13 more
europepmc +1 more source
Inflammatory and Immunological Basis of Periodontal Diseases
The periodontal lesion emerges as an evolving immunological battlefield, where host–microbiome interactions, dysregulated immune responses, fragile resolution mechanisms, and inflammophilic dysbiosis converge to shift the balance from homeostasis to unrestrained tissue destruction.
Giacomo Baima +3 more
wiley +1 more source
Development of Single-Molecule Enzyme Activity Assay for Serine Hydrolases Using Activity-Based Protein Labeling Probes. [PDF]
Ishii S +7 more
europepmc +1 more source
A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression [PDF]
de la Luz Garcia-Hernandez, Maria +5 more
core +2 more sources
Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma models. [PDF]
Gallegos CA +13 more
europepmc +1 more source

